Arbidol: The current demand, strategies, and antiviral mechanisms.

Kang, Yue; Shi, Yin; Xu, Silu

Kang, Yue; Shi, Yin; Xu, Silu.

Afiliação

Kang Y; Jiangsu Key Laboratory of Neurodegeneration, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Shi Y; Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Xu S; Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Immun Inflamm Dis ; 11(8): e984, 2023 08.

Article em En | MEDLINE | ID: mdl-37647451

Assuntos

COVID-19; Influenza Humana; Humanos; Antivirais/farmacologia; Antivirais/uso terapêutico; Influenza Humana/tratamento farmacológico; Antagonistas de Receptores de Angiotensina; Inibidores da Enzima Conversora de Angiotensina

Palavras-chave

antiviral strategy; arbidol; influenza virus; viral infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Influenza Humana / COVID-19 Limite: Humans Idioma: En Revista: Immun Inflamm Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google